It’s open season for untested peptide injections.
Health and Human Services Secretary Robert F. Kennedy Jr. declared on Wednesday that patients will now be allowed broad access to untested and unproven peptide drugs popularized by health influencers. The move has already drawn immediate and intense concern from scientists and medical professionals, who are wary that the decision will result in confusion and harm to consumers.
In a sweeping and seemingly unilateral decision by Kennedy, the HHS has directed the Food and Drug Administration (FDA) to not take action against pharmacies that sell six peptides including BPC-157, KPV, and TB-500. According to sources who spoke to the Associated Press, the decision was made without input from scientists at the FDA, who generally oppose the change.
“Based on the available evidence, including the recommendations of a recent Pharmacy Compounding Advisory Committee, the Secretary has determined that the policy advances patient choice and freedom while appropriately protecting patient safety,” reads the decision.
